{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:46:36Z","timestamp":1780497996528,"version":"3.54.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The prosthetic surgical above-knee bypass (pAKB) is a standard therapy in superficial femoral artery (SFA) occlusive disease in absence of suitable vein. Viabahn graft has been established as a promising alternative. Since limited comparative data are available, we conducted a retrospective study to compare long-term outcomes of these 2 therapies in a real-world setting.<\/jats:p>\n            <jats:p>Records of 52 patients (60 limbs), who were treated by pAKB (29 limbs) or Viabahn (31 limbs) were reviewed. Patients were followed up by clinical assessment, physical examination, and resting ankle brachial index (ABI) after 3, 6, 12 months and yearly thereafter. Long-term data were available for 97% in the Viabahn and 93% for pAKB after 73\u200a\u00b1\u200a3.7 months (mean\u200a\u00b1\u200astandard error [SE]).<\/jats:p>\n            <jats:p>Long-term primary and secondary patencies in Viabahn group were 40% and 70%, respectively, after 63\u200a\u00b1\u200a2.8 months (mean\u200a\u00b1\u200aSE). Total lesion length was 19\u200a\u00b1\u200a11.06\u200acm (mean\u200a\u00b1\u200aSE), graft size was 6\u200a\u00b1\u200a0.72\u200amm (mean\u200a\u00b1\u200aSE). Hospital stay was 4.8\u200a\u00b1\u200a0.72 days (mean\u200a\u00b1\u200aSE). Limb salvage was achieved in 90%. Patients in the pAKB group showed a total lesion length of 24.39\u200a\u00b1\u200a1.97\u200acm (mean\u200a\u00b1\u200aSE), graft size was 7\u200a\u00b1\u200a0.99\u200amm (mean\u200a\u00b1\u200aSE). Long-term analysis after 83\u200a\u00b1\u200a6.8 months (mean\u200a\u00b1\u200aSE) revealed a primary patency of 78% with a secondary patency of 94%. Hospital stay was 10.4\u200a\u00b1\u200a1.27 days (mean\u200a\u00b1\u200aSE). Limb salvage was ensured in 97%. Long-term primary patency was lower for Viabahn (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.044), secondary patency (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.245), and leg salvage (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.389) were not significantly different. However, hospital stay was shorter (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0002) for Viabahn.<\/jats:p>\n            <jats:p>Long-term analysis of Viabahn revealed a significantly lower primary patency, a similar secondary patency, limb salvage, and significantly shorter hospital stay when compared with pAKB. Our data suggest that pAKB is still a valuable option in patients suitable for an open operation. However, Viabahn can be used as a less invasive treatment in high risk patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000012449","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T22:40:00Z","timestamp":1538606400000},"page":"e12449","source":"Crossref","is-referenced-by-count":8,"title":["Viabahn stent graft compared with prosthetic surgical above-knee bypass in treatment of superficial femoral artery disease"],"prefix":"10.1097","volume":"97","author":[{"given":"Narges","family":"Waezi","sequence":"first","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, University Medical Center, Georg-August University, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Saha","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, University Medical Center, Georg-August University, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Bougioukas","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Voelklingen Heart Centre, V\u00f6lklingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Emmert","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, University Medical Center, Georg-August University, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard Christoph","family":"Danner","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, University Medical Center, Georg-August University, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassina","family":"Baraki","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, University Medical Center, Georg-August University, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Kutschka","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, University Medical Center, Georg-August University, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Zenker","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, University Medical Center, Georg-August University, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomislav","family":"Stojanovic","sequence":"additional","affiliation":[{"name":"Vascular and Endovascular Surgery Hospital Wolfsburg, Wolfsburg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Fawad","family":"Jebran","sequence":"additional","affiliation":[{"name":"Department of Thoracic and Cardiovascular Surgery, University Medical Center, Georg-August University, G\u00f6ttingen"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230915","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"R2-20230915","first-page":"683","article-title":"Role of total endoluminal superficial femoral artery bypass","volume":"52","author":"Gable","year":"2011","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1148\/radiology.217.1.r00se0595","article-title":"Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group","volume":"217","author":"Lammer","year":"2000","journal-title":"Radiology"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jvs.2008.08.041","article-title":"Randomized comparison of ePTFE\/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease","volume":"49","author":"McQuade","year":"2009","journal-title":"J Vasc Surg"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.RVI.0000052290.26939.cb","article-title":"Hemobahn stent-grafts for treatment of femoropopliteal arterial obstructions: midterm results of a prospective trial","volume":"14","author":"Jahnke","year":"2003","journal-title":"J Vasc Interv Radiol"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1583\/05-1799.1","article-title":"Value of the hemobahn\/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience","volume":"13","author":"Fischer","year":"2006","journal-title":"J Endovasc Ther"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejvs.2005.04.027","article-title":"Efficacy of Hemobahn in the treatment of superficial femoral artery lesions in patients with acute or critical ischemia: a comparative study with claudicants","volume":"30","author":"Hartung","year":"2005","journal-title":"Eur J Vasc Endovasc"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ejvs.2007.09.005","article-title":"Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: which factors influence long-term patency?","volume":"35","author":"Alimi","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R9-20230915","first-page":"278","article-title":"One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft","volume":"21","author":"Farraj","year":"2009","journal-title":"J Invasive Cardiol"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"130.e1","DOI":"10.1016\/j.jvs.2017.01.065","article-title":"Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions","volume":"66","author":"Ohki","year":"2017","journal-title":"J Vasc Surg"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jvs.2006.08.074","article-title":"Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease","volume":"45","author":"Kedora","year":"2007","journal-title":"J Vasc Surg"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jvs.2010.03.071","article-title":"Four-year randomized prospective comparison of percutaneous ePTFE\/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease","volume":"52","author":"McQuade","year":"2010","journal-title":"J Vasc Surg"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1538574413495964","article-title":"Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft","volume":"47","author":"Jebran","year":"2013","journal-title":"Vasc Endovascular Surg"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford","year":"1997","journal-title":"J Vasc Surg"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/1538574411414923","article-title":"Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease","volume":"45","author":"Donker","year":"2011","journal-title":"Vasc Endovascular Surg"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1067\/mva.2002.86","article-title":"Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial","volume":"37","author":"Klinkert","year":"2003","journal-title":"J Vasc Surg"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejvs.2003.12.027","article-title":"Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature","volume":"27","author":"Klinkert","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R19-20230915","first-page":"CD001487","article-title":"Graft type for femoro-popliteal bypass surgery","volume":"2","author":"Ambler","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R20-20230915","first-page":"187","article-title":"Results from an Italian multicentric registry comparing heparin-bonded ePTFE graft and autologous saphenous vein in below-knee femoro-popliteal bypasses","volume":"53","author":"Dorigo","year":"2012","journal-title":"J Cardiovasc Surg (Torino)"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/00000658-198512000-00020","article-title":"Saphenous vein or PTFE for femoropopliteal bypass. A prospective randomized trial","volume":"202","author":"Tilanus","year":"1985","journal-title":"Ann Surg"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jvs.2010.02.010","article-title":"A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting","volume":"52","author":"Takagi","year":"2010","journal-title":"J Vasc Surg"},{"key":"R23-20230915","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0741-5214(97)70317-3","article-title":"Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group","volume":"25","author":"Abbott","year":"1997","journal-title":"J Vasc Surg"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jvs.2014.05.049","article-title":"A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass","volume":"60","author":"Rychlik","year":"2014","journal-title":"J Vasc Surg"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00270-008-9331-7","article-title":"Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review","volume":"31","author":"Met","year":"2008","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N Engl J Med"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1583\/11-3627.1","article-title":"Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial","volume":"19","author":"Laird","year":"2012","journal-title":"J Endovasc Ther"},{"key":"R28-20230915","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ccd.22128","article-title":"Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions","volume":"74","author":"Dick","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"R29-20230915","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1583\/05-1672.1","article-title":"Long-segment SFA stenting--the dark sides: in-stent restenosis, clinical deterioration, and stent fractures","volume":"12","author":"Schlager","year":"2005","journal-title":"J Endovasc Ther"},{"key":"R30-20230915","doi-asserted-by":"crossref","first-page":"386.e4","DOI":"10.1016\/j.jvs.2013.01.050","article-title":"VIBRANT investigators. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease","volume":"58","author":"Geraghty","year":"2013","journal-title":"J Vasc Surg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201810050-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T21:57:40Z","timestamp":1694815060000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201810050-00016"}},"subtitle":["Long-term results of a retrospective analysis"],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000012449","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}